Bunnage Mark E. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Bunnage Mark E.（CIK 2100735）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-05-19）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 33 | $14,964 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 582 | $282,334 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 620 | $301,537 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 买入 | 2,584 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 1,110 | $536,962 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 2,437 | $1.2M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 1,182 | $559,890 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 2,283 | $1.1M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 1,127 | $527,898 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | 卖出 | 2,021 | $930,529 |
来源：SEC Form 4 申报文件 · 截至 2026-05-19